Accro Bioscience Secures IND Approval for Vitiligo Treatment Trial in China #China #Suzhou #Fosun_Pharma #AC-201 #Accro_Bioscience
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialFosun Pharma Reveals Bold H-Share Buyback Initiative Up to HK$1 Billion #China #Shanghai #Fosun_Pharma #Gland_Pharma #H-Share_Buyback